# Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance

> **NCT00665652** · PHASE2 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 8 (actual)

## Conditions studied

- Neuropathy
- Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT00665652
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2011-05-19
- **Final completion:** 2011-05-19
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The study has been suspended for slower than anticipated enrollment to date.
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665652, "Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00665652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*